Liankang Biotechnology Group (00690.HK): Bogutai? (Terripatide injection) application for marketing has been officially accepted by the State Food and Drug Administration
Jia Yueting’s FF responded: There will be no risk of delisting when submitting financial reports in a timely manner, and the expected losses in the third quarter will increase